Big Bets or Big Blunders: Notable Insider Moves Toward the End of Feb/Early Mar 2025 - MRNA, AMRC, WD, BLMN, ECPG, SEDG, RUN, IHRT, PR, UAN, CORZ, ZD, THM, IFF, BEN, MAC, LAB, FMC, STRL, TNET, TBLA, MTDR, CCO, KTOS, FLGT
📅 Date: Mar 7, 2025📊 Category: Insider Purchases 🔍 Quick Take: Last Week’s Insider Action (Select List) Who’s Buying? CEOs, CFOs, Directors 10% Owners Other Key Executives Which Stocks? Moderna (MRNA) Ameresco (AMRC) Walker & Dunlop (WD) Bloomin' Brands (BLMN) Encore Capital Group (ECPG) Solaredge Technologies (SEDG) Sunrun (RUN) Iheartmedia (IHRT) Permian Resources (PR) CVR Partners (UAN) Core Scientific (CORZ) Ziff Davis (ZD) International Tower Hill Mines (THM) International Flavors & Fragrances (IFF) Franklin Resources (BEN) Macerich (MAC) Standard Biotools (LAB) FMC Corporation (FMC) Sterling Infrastructure (STRL) Trinet (TNET) Taboola.com (TBLA) Matador Resources (MTDR) Kratos Defense & Security Solutions (KTOS) Clear Channel Outdoor Holdings ( CCO) Vimeo (VMEO) Fulgent Genetics (FLGT) Why Does It Matter? Bullish signals 1️⃣ The...
Big Bets or Big Blunders: Notable Insider Moves In the First Half of February 2025 - ASH, IMNM, EL, MRK, SIRI, KMT, MAGN, OXY, UFI, MTH, TKO, HI, ENTA, NVCT, OCX, SYNA, NINE, HP, BZH, MNR, BDX, LFUS, MUR, AESI
Big Bets or Red Flags? What Insider Buying Tells Us
CEOs, directors, and 10% owners are making big moves—and they aren’t subtle about it. From Ashland’s bullish buys to Buffett’s continued love affair with SiriusXM and Occidental, insider trades are signaling some serious market confidence. Are these just corporate optics or a true sign of undervalued opportunities? Let’s break down the biggest insider moves—and what they mean for your portfolio.
Big Bets or Big Blunders: Notable Insider Moves Toward the End of January 2025 - ALLY, TKO, ADBE, GM, SFD, BATRA, XRAY, TREX
Insider Buys Are Heating Up—Should You Pay Attention?
CEOs and key executives are making big bets on stocks like Ally Financial, Adobe, and TKO Group. With millions of insider dollars pouring in, are these signals of strength or just corporate window dressing? From undervalued gems to conviction buys, here’s what the market pros are seeing—and why it matters for your portfolio.
Biohaven (BHVN), Voxx (VOXX), Asana (ASAN), and Carnival (CUK, CCL) Lead Insider Purchases the Week of 10/9/2023
Biohaven (BHVN), Voxx (VOXX), Asana (ASAN), and Carnival (CUK, CCL) constituted some of the top insider purchases the Week of 10/9/2023. CEO Vlad Coric, an astute biotech entrepreneur and investor (you can read about him here) bought $10 million worth of stock of BHVN at $22.00 a share, as did director John Childs, on 10/5. After Pfizer spent $11.6 billion to buy Biohaven's migraine treatment assets, including an already approved drug, the firm's operations focus on treatments for epilepsy, spinal muscular atrophy, and a protein degradation program with multiple potential uses. Steven Downing, Director, bought over $15 million worth of shares in the auto and consumer electronics supplier Voxx International Corp. (VOXX). The stock actually rallied more than 20% on 10/11 after Gentex Corp....
Largest Insider Stock Purchases Belonged in Biotech and Energy the Week of 9/18/23
Two verticals constituted the lion share of insider purchases last week. In biotech, Neumora Therapeutics (NMRS) saw Amgen (AMGN) and the CEO buying shares. Rayzebio (RYZB) and Ambrx Bio (AMAM) also saw large insider accumulation. In the energy field, Chargepoint Holding (CHPT), Highpeak Energy (HPK) (where both the CEO and the President bought), Enphase Energy (ENPH), CNX Resources (CNX), and Riley Exploration (REPX) also saw insiders acquire substantial amounts of shares. Outside the biotech and energy verticals, of note are insider purchases at Maplebear (Instacart) (CART), Asana (ASAN) (where the CEO has been buying shares for months), and Westrock Coffee (WEST). CHPT buyer Wil VanLoh founded Quantum Energy Partners in 1998 and serves as CEO of the firm and as Chairman...
Revisiting Insider Purchases Made the Second Week of May 2021: Scary!
Insiders purchased a lot shares of biotech and small medical device companies the Second Week of May 2021 (often shortly after IPO), only to lose their shirt! If you followed the smart crowd, and invested at around the same time, you are probably sitting on severe losses. Most stocks have seen an at least 50% haircut, and that's after accounting for some of the recovery of late. Neurospace (NPCE), Design Therapeutics (DSGN), Werewolf Therapeutics (WOLF), Reneo Pharmaceuticals (RPHM), Cyclerion Therapeutics (CYCN), and Nuvation Bio (NUVB), to name a few, have all collapsed or near-collapsed. A couple of stocks are indeed trying to recover. Unsurprisingly, all of the above are unprofitable ventures. The lesson is clear. Best to stay away from unprofitable biotech and...
Insiders Buy Shares at Varonis Systems
Key insiders including the CEO, CFO, and SVP of Sales, bought shares of Varonis Systems (VRNS). All three are key decision-makers. the purchases are also large enough that they warrant scrutiny. The Company is expected to be profitable over the next couple of years, as is made clear below: Meanwhile, the 17 analysts offering 12-month price forecasts for Varonis Systems have a median target of 25.00, with a high estimate of 63.00 and a low estimate of 20.00. The median estimate represents a +50.69% increase from the last price of 16.59. After their recent collapse (see stock chart below), the shares seem rather cheap. Varonis Systems, Inc. (Varonis)...